Summary

for people ages 18 years and up (full criteria)
at Sacramento, California and other locations
study started
estimated completion
Christopher Bowlus, MD

Description

Summary

This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.

Keywords

Biliary Cirrhosis, Primary Cholangitis Liver Cirrhosis, Biliary

Eligibility

You can join if…

Open to people ages 18 years and up

  • Adult patients (age 18 or older) being treated or managed for PBC

You CAN'T join if...

  • Inability to provide written informed consent
  • Simultaneous enrollment in another prospective registry or clinical trial or study where PBC treatment outcomes are reported, except where approved or conducted as an adjunct project of TARGET-PBC

Locations

  • University of California Davis accepting new patients
    Sacramento California 95817 United States
  • Stanford University Medical Center accepting new patients
    Palo Alto California 94304 United States

Lead Scientist

  • Christopher Bowlus, MD
    Professor, Gastroenterology and Hepatology. Authored (or co-authored) 138 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Target PharmaSolutions, Inc.
Links
Sign up for this study
ID
NCT02932449
Study Type
Observational
Last Updated